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Abstract
Dystrophin contributes to force transmission and has a protein-scaffolding role for a variety of signaling complexes in
skeletal muscle. In the present study, we tested the hypothesis that the muscle adaptive response following mechanical
overloading (ML) would be decreased in MDX dystrophic muscle lacking dystrophin. We found that the gains in muscle
maximal force production and fatigue resistance in response to ML were both reduced in MDX mice as compared to healthy
mice. MDX muscle also exhibited decreased cellular and molecular muscle remodeling (hypertrophy and promotion of
slower/oxidative fiber type) in response to ML, and altered intracellular signalings involved in muscle growth and
maintenance (mTOR, myostatin, follistatin, AMPKa1, REDD1, atrogin-1, Bnip3). Moreover, dystrophin rescue via exon
skipping restored the adaptive response to ML. Therefore our results demonstrate that the adaptive response in response to
ML is impaired in dystrophic MDX muscle, most likely because of the dystrophin crucial role.
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Introduction
Skeletal muscle exhibits a crucial capacity to adapt to changing
use.Inresponsetorepeatedhigh-forcecontractions,i.e.,mechanical
overloading (ML), both absolute maximal force production and
fatigue resistance of the muscle markedly increase. Tension, stretch
anddeformationgeneratedduringML,togetherwithotheractivity-
related signals (e.g. muscle action potential, metabolites…), are
sensedandinturnactivatedifferentintracellularsignalingpathways
that converge to induce muscle cellular and molecular adaptations,
such as hypertrophy and fiber-type conversion, resulting in muscle
performance improvement [1,2,3,4,5].
The gain in absolute maximal force induced by ML is, at least
partly, attributed to muscle hypertrophy, since absolute maximal
force is roughly proportional to muscle cross-sectional area.
Muscle hypertrophy in response to ML results from increased
protein synthesis via activation of the mammalian target of
rapamycin (mTOR) signaling pathway [6,7]. More precisely, it is
the mTOR complex-1 (mTORC1) that contains mTOR and the
rapamycin-sensitive raptor subunit that promotes protein synthesis
via the phosphorylation of the initiation factor-4E binding protein-
1 and the S6 kinase (S6K) that in turn phosphorylates at the S240/
244 site the ribosomal S6 protein (rS6)[1,2]. Akt is also activated
by ML [6] and it is known that genetic activation of Akt promotes
muscle hypertrophy [8,9]. Recently, we demonstrated that the
alpha-1 isoform of the AMP-activated protein kinase (AMPK-a 1)
plays an important role in limiting muscle growth during ML, via
the reduced activation of mTOR signaling [10]. In addition, it has
been shown that myostatin is down-regulated in response to ML
[11]. Since myostatin deactivates mTOR [12,13,14], these results
suggest that together with AMPK, myostatin also limits muscle
hypertrophy induced by ML. In addition, the myostatin inhibitor
follistatin [15] and the stress response genes REDD1 and REDD2
(regulated in development and DNA damage response)[1,16] are
possibly involved in the control of mTOR signaling in response to
ML. Of note, the activation of the mitogen-activated protein
kinase pathway (MAPK) may be not sufficient to induce muscle
growth [17,18] and a recent study reported that satellite cells are
not necessary for a robust ML-induced hypertrophy [19].
The fast/glycolytic -to slow/oxidative fiber conversion is likely
the cellular and molecular adaptation responsible for the increase
in fatigue resistance induced by ML. Indeed, it is well established
that slow/oxidative fibers expressing type-1 and -2a myosin heavy
chain (MHC-1 and MHC-2a) are more fatigue-resistant than fast/
glycolytic fibers expressing MHC-2x and MHC-2b [20]. Calci-
neurin/NFAT signaling is a key player in the promotion of the
slow/oxidative fiber phenotype [3,21]. Pharmacological inhibition
or genetic loss of calcineurin blocks the fast/glycolytic -to slow/
oxidative fiber-type conversion induced by ML [22,23,24]. The
peroxisome proliferator-activated receptor c coactivator-1 (PGC-
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signaling pathways have also been proposed to promote the
formation of slow/oxidative fibers [3,5,21,25].
Dystrophin, a costameric protein, is known to operate as a
physical link between the actin cytoskeleton and laminin in the
extracellular matrix, allowing likely the force to be transmitted
outside of the cell and vice-versa [26]. This is supported by the
findings that in the MDX mice that lacks dystrophin, muscle
specific maximal force (force adjusted to muscle size) production is
reduced [27] whereas exon skipping-mediated dystrophin rescue
improves it [28]. Thus, force transmission with the participation of
dystrophin possibly contributes to the sensing of the tension/
deformation. Dystrophin may be also required for the membrane
localization and function of certain components of signaling
pathways (e.g. mechanoreceptor, dihydropyridine receptor,
nNOS) acting in muscle growth and maintenance
[29,30,31,32,33]. Several studies support this hypothesis by
showing aberrant activation of Akt and mTOR, calcineurin, and
MAPK pathways in the MDX mice [34,35,36,37,38]. Together
these results suggest that dystrophin may contribute to the
mechanotransduction and other activity-signaling pathways me-
diating muscle adaptations in response to ML.
The general aim of this study was to determine the adaptive
response to ML of skeletal muscle from MDX mice, a murine
model of Duchenne muscular dystrophy (DMD) causing severe
muscle weakness for yet not fully understood reasons. We studied
the effect of ML on MDX dystrophic muscle performance
(maximal force production, fatigue resistance) and cellular and
molecular remodeling (hypertrophy, fiber-type conversion…). ML
was induced by surgical removal of the synergic muscles of the
plantaris hindlimb muscle, a well-established rodent model
[6,7,10,19,22,23,24,39,40,41,42,43]. More specifically, we tested
the hypothesis that the muscle adaptive response following ML
would be decreased in MDX mice as compared to healthy mice.
We also determined whether dystrophin rescue via exon skipping
would restore dystrophic muscle adaptations to ML. To our
knowledge, this has not yet been studied.
Results
Reduced gain in muscle performance: maximal force
In situ plantaris muscle force production in response to nerve
stimulation showed important changes 2 months after ML. The
muscle absolute maximal force in MDX mice with mechanical
loading (MDX+ML) and C57+ML mice were markedly increased
as compared to MDX mice and C57 mice (Figure 1a). However,
muscle absolute maximal force in MDX+ML mice was lower as
compared to C57+ML mice, indicating that the increase in muscle
absolute maximal force is lower in MDX+ML mice (+40%) as
comparedtoC57+MLmice(+204%)mice.Thisdifferencebetween
the 2 strains of mice was first explained by the reduced increase in
muscle weight in response to 2-month ML in MDX+ML mice
(+24%)ascomparedtoC57+MLmice(+80%)mice(Figure1b).The
factthatincontrasttoC57+MLmice,musclespecificmaximalforce
wasnotincreasedinMDX+MLmiceinresponseto2 monthsofML
(Figure 1c) was also responsible for the smaller increase in muscle
absolute maximal force in MDX+ML mice.
To test the possibility that a defect in the contractile machinery
(myofilaments) could be directly responsible for the maintained
muscle specific maximal force observed in the MDX+ML mice,
we also determined the force generation of plantaris skinned
muscle fibers in response to maximal activation by calcium
2 months after ML. Data obtained from skinned fibers expressing
MHC-2b and MHC-2x were pooled since no difference was
observed between these 2 types of fibers. We found that fiber
specific maximal force of MDX+ML mice was reduced when
compared to MDX mice (218%) whereas that of C57+ML mice
did not change following ML (Figure 1d).
We also observed an increased fibrosis (decreased concentration
of contractile material) in the MDX mice in response to 2 month-
ML as shown with Sirius red staining (Figures 2a and 2b), which
may partly explain the deficit in muscle specific maximal force
observed in MDX+ML. Regenerating fibers were recently
reported following ML [19,54] and are thought to produce less
specific maximal force than mature fibers. Therefore, we checked
the possibility that ML induced a greater increase in the number of
regenerating fibers in MDX+ML mice as compared to C57+ML
mice. These regenerating fibers would consequently have a greater
contribution to force production in the MDX+ML mice. Nuclei
and laminin were stained to count the number of regenerating/
regenerated fibers that contain one or more centronuclei 2 months
after ML. However, in contrast to C57+ML mice, we observed
that there was no increase in the percentage of centronucleated
fibers in response to ML in MDX+ML (Figure 2c). No notable
expression of neonatal or embryonic MHC was found in both
strains 2 months after ML (data not shown), indicating that these
centronucleated fibers were regenerated. Since the fast muscle
fibers expressing MHC-2b could produce a higher specific
maximal force, we tested the possibility that ML reduced more
efficiently the percentage of fast fibers in MDX+ML mice as
compared to C57+ML mice. However, in contrast to C57+ML
mice, immunostaining for MHC isoform revealed that the
percentage of fibers expressing MHC-2b did not decrease in
MDX+ML mice in response to 2 months ML (Figure 2d). It
should ne noted that a substantial number of these fibers co-
expressed MHC-2x. Unfortunately, it was not possible to
distinguish pure and hybrid fibers expressing MHC-2b.
Reduced gain in muscle performance: fatigue resistance
Togetherwiththeincreaseinabsolutemaximalforceproduction,
muscles from both MDX+ML mice and C57+ML mice improved
their fatigue resistance in response to 2-month ML (Figure 1e).
However, the improvement in muscle fatigue resistance was less
marked in MDX+ML mice (+36%) as compared to C57+ML mice
(+85%).ThefactthatincontrasttoC57+MLmicethepercentageof
fibers expressing MHC-2b (less fatigue resistant fibers) did not
decreaseinMDX+MLmice(Figure2d)mightberesponsibleforthis
difference. Since the calcineurin/NFAT, PGC-1, and PPAR
signaling pathways promote the formation of slow/oxidative/
fatigue-resistant fibers [3], we further analysed these pathways
7 daysafterML[41]totestthepossibilitythattheyarelessactivated
inMDX+MLmice.WefoundthatthetranscriptlevelsofNFATc1a,
PGC1a1a and PPARß were globally reduced by ML in both mice
strains (Figure S1a–c).
Fiber atrophy and altered catabolic processes
To further analyze the reduced muscle hypertrophy in
MDX+ML mice in response to ML, we counted the fiber number
observed in a muscle cross-section, using laminin labeling
2 months after ML. We found that in response to ML, the fiber
number increased in both MDX+ML mice and C57 +ML mice,
with no notable difference between the two mice strains (+71%
versus + 84%)(Figure 3a). In contrast to C57+ML mice,
MDX+ML mice increased the number of fibers expressing
MHC-2b and did not change those expressing MHC-2x
(Figure 3b). In both strains however, the number of fibers
expressing MHC-2a or MHC-1 increased (Figure 3b).
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after ML to confirm that the reduced muscle hypertrophy in
MDX+ML mice resulted from a smaller fiber diameter in
MDX+ML mice. This was in fact the case since the mean diameter
of fibers in MDX+ML mice was reduced by ML (Figure 3c).
However, this was not explained by a smaller percentage of large
diameterfibersexpressingMHC-2b(Figure3d),butbythediameter
of the fibers expressing MHC-2b or MHC-2a that was reduced by
ML in MDX+ML mice (Figures 3d–e).
Together with the anabolic processes (regulated by the mTOR
pathway, see below), the catabolic processes control muscle size.
Thus, we addressed the role of catabolic processes in the reduced
musclehypertrophy(reduceddiameterofthefibers)inducedbyML
in MDX mice. We studied the ubiquitin-proteasomal pathway
responsibleforthemyofibrillarmuscleproteindegradation,possibly
Figure 1. Reduced muscle performance gain and hypertrophy and decrease in contractile machinery function following 2 month-
ML in MDX mice. Absolute muscle maximal force (a), muscle weight (b), muscle specific maximal force (c), specific maximal force of skinned muscle
fibers (d), and muscle fatigue resistance (e) after 2 months of ML. a: significantly different from unoverloaded muscle (p,0.05). b: significantly
different from corresponding C57 mice (p,0.05). n=14–26/group for absolute and specific muscle maximal forces and n=30/group (at least 7 per
animal) for specific maximal force skinned fibers.
doi:10.1371/journal.pone.0035346.g001
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pathway is negatively controlled via a set of E3 ligase-encoding
genes, such as atrogin-1 [55]. Atrogin-1 mRNA decreased globally
less in response to ML in MDX+ML than in C57+ML mice
(Figure S2a). Autophagy, involving a battery of genes such as LC3
andBnip3,alsoplaysanimportantroleinthedegradationofmuscle
proteins [55]. We found that LC3 mRNA similarly decreased in
MDX+ML and C57+ML mice (at day 7 respectively –31% versus -
33%)(Figure S2b). However Bnip3 mRNA decreased to a some-
what lesser extent in MDX+ML as compared to C57+ML (263%
versus 282% at day 7)(Figure S2c).
Altered anabolic signaling pathways
To determine whether the reduced hypertrophy in response to
ML in MDX+ML mice is also caused by a lower activation of
mTOR signaling, we measured the phosphorylation level of the
key downstream effector of mTOR, rS6, after 7 days of ML
[10,41,56]. We found a smaller increase in rS6 phosphorylation in
MDX+ML mice (+360%) as compared to C57+ML mice
(+796%)(Figures 4a–b). Of note the level of rS6 phosphorylation
was lower in MDX+ML mice than in C57+ML mice. In line with
this finding, we also observed that ML caused Akt phosphorylation
to a reduced extent in MDX+ML mice (+88%) than in C57+ML
mice (+198%)(Figure 4c).
We measured the AMPKa1 activity at day 7 [10,41] to test the
hypothesis that the reduced mTOR activation was due to hyper-
activation of AMPKa1 activity. We found that AMPKa1 activity
was increased in a similar way in MDX+ML mice (+1,141%) and
C57+ML mice (+1,006%) 7 days after ML; however AMPKa1
activity was higher in MDX+ML mice as compared to C57+ML
mice (Figure 4d).
We also determined whether there was a smaller reduction in
myostatin expression, a mTOR deactivator, in MDX+ML mice in
response to ML as compared to C57+ML mice at day 7. We
observed that the level of myostatin mRNA decreased less in the
MDX+ML mice in response to ML (274%) than in the C57+ML
mice (293%)(Figure 4e). Follistatin is known to antagonize
myostatin, to be regulated by mTOR and to play an important
role as a myoblast fusion/growth promoting factor [15]. We found
that the increase in follistatin mRNA induced by 7-day ML was
reduced in MDX+ML (+119%) as compared to C57+ML
(+331%)(Figure 4f).
Both REDD1 and REDD2 genes (regulated in development and
DNA damage responses 1 and 2) are negative regulators of mTOR
signaling, REDD2 overexpression diminishing the activation of
mTOR in response to mechanical signal [16]. Therefore, we also
measured the expression of both genes at day 7. In contrast to
C57+ML mice, there was no ML-induced decrease in REDD1
mRNA in MDX+ML mice (Figure 4g). Concerning REDD2
mRNA,it was reduced ina similar way in MDX+ML mice (273%)
and C57+ML mice (–82%) 7 days after ML (Figure 4h).
Dystrophin rescue restored the adaptive response
Together, our results suggest that dystrophin is essential for a
normal response to ML. To further substantiate the role of
dystrophin in the adaptive response to ML, we performed a
dystrophin rescue experiment. We evaluated the effect of U7-
mediated dystrophin (U7-DYS) rescue in plantaris muscle [44]. We
injected U7-DYS contruct to MDX mice 1 month before ML
(MDX+ML+DYS) and we studied the muscle following 1-month
ML.
In contrast to C57+ML mice, MDX+ML mice did not increase
absolute maximal force and fatigue resistance and reduce specific
maximal force in response to 1-month ML (Figures 5a–c),
confirming that the adaptative response was blunted in MDX+ML
mice as compared to C57+ML mice. MDX+ML+DYS muscles
immunostained for dystrophin expression revealed high levels of
dystrophin expression properly localized to the fiber sarcolemma
Figure 2. Muscle histology following 2 month-ML in MDX mice.
Fibrosis (a and b), percentage of centronucleated muscle fibers (c) and
percentage of the different types of muscle fibers (d) after 2 months of
ML. Representative images of fibrosis (red) on Sirius red staining cross-
section (a) shown increased fibrosis in MDX and MDX+ML mice. Of note,
since muscle fiber can express more than one MHC, the total
percentage of the different muscle fiber types added up to well over
100%. n=3–4/group for fibrosis and n=5–8 for percentage of fibers. a:
significantly different from unoverloaded muscle (p,0.05). b: signifi-
cantly different from corresponding C57 mice (p,0.05).
doi:10.1371/journal.pone.0035346.g002
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PLoS ONE | www.plosone.org 4 April 2012 | Volume 7 | Issue 4 | e35346Figure 3. Cellular aspects of the attenuation of muscle hypertrophy following 2 month-ML in MDX mice. Number (a and b) and
diameter (c,d and e) of the muscle fibers after 2 months of ML. Of note, since muscle fiber can express more than one MHC, the sum of the number of
the different types of muscle fibers exceeded the total number of fibers. The representative images (e) show reduced size of fibers expressing MHC-
2b following ML. Cross-sections were revealed for MHC-2b (red), MHC-2a (green) and MHC-1 (blue) reactivity. Scale bar=20 mm. a: significantly
different from unoverloaded muscle (p,0.05). b: significantly different from corresponding C57 mice (p,0.05). n=5–8/group.
doi:10.1371/journal.pone.0035346.g003
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Interestingly, the delivery of U7-DYS construct in MDX mice was
able to fully restore the gain of absolute maximal force induced by
1 month ML. Indeed, ML combined with U7-DYS in MDX
induced similar increase in absolute maximal force (+90%) as ML
alone in C57 mice (+77%). This was explained by the fact that U7-
DYS prevented the drop in specific maximal force in
MDX+ML+DYS (Figure 5c), without affecting fibrosis (Figur-
e S3b–c). Moreover, U7-DYS partially restored the increase in
muscle fatigue resistance induced by ML in MDX+ML+DYS
Figure 4. Altered activation (p-rS6 and p-Akt) and regulation (AMPKa1, myostatin, follistatin, REDD1 and REDD2) of mTOR
signaling pathway at 7 days following ML in MDX mice. p-rS6 (a, b), p-Akt (a, c), AMPKa1 activity (d), myostatin (e), follistatin (f), REDD1 (g) and
REDD2 (h) mRNA after 7 days of ML. The image (a) show representative blots of p-rS6 and p-Akt. a: significantly different from unoverloaded muscle
(p,0.05). b: significantly different from corresponding C57 mice (p,0.05). n=5–12/group.
doi:10.1371/journal.pone.0035346.g004
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weight in MDX+ML+DYS (Figure 5d) that was associated with a
greater diameter for the fibers expressing dystrophin as compared
to the fibers not expressing dystrophin (Figure S3d).
Discussion
In the present study, we reported for the first time that the
muscle adaptive response following ML was impaired in MDX
mice and dystrophin rescue restored it. Our study strongly suggests
that dystrophin plays an important role in the muscle performance
gain and remodeling following ML.
Reduced performance gain
Muscle performance was improved to a lesser extent in
MDX+ML mice as compared to C57+ML mice. The markedly
reduced increase in muscle absolute maximal force (both 1 and
2 months after ML; at month 2:+40% versus+204%) resulted from
the fact that muscle specific maximal force was reduced (1 month-
ML) or did not increase (2 month-ML) in MDX mice. The
reduced specific maximal force of the fast fibers in MDX+ML
mice explains this difference between the two mice strains. We
would suggest that the reduced specific maximal force of the
muscle fibers was caused by a lower concentration of contractile
proteins since we found that fibers were atrophied in the
MDX+ML mice and dystrophin rescue increased their diameter
(see below). In addition, we cannot exclude the possibility that ML
increased the alterations in subcellular sarcomere microarchitec-
ture in MDX mice [57]. The smaller increase in muscle absolute
maximal force induced by 2 month-ML in MDX+ML mice was
also caused by a reduced muscle hypertrophy (see below).
Together with the reduced gain in muscle absolute maximal
force, we also reported an attenuated increase in muscle fatigue
resistance in response to ML in MDX mice (both at 1 and
Figure 5. Restoration of the adaptive response to 1 month ML by dystrophin rescue. Absolute (a) and specific (b) muscle maximal forces,
weight (c) and fatigue resistance (d) and after 1-month of ML combined with U7-mediated dystrophin rescue. a: significantly different from
unoverloaded muscle (p,0.05). b: significantly different from corresponding C57 mice (p,0.05). c: significantly different from MDX+ML (p,0.05).
n=6/group.
doi:10.1371/journal.pone.0035346.g005
Mechanical Overloading and Absence of Dystrophin
PLoS ONE | www.plosone.org 7 April 2012 | Volume 7 | Issue 4 | e353462 months; at 2 months:+36 versus +85%). This was associated
with a reduction in the fast/glycolytic to slow/oxidative fiber-type
conversion in response to ML (higher percentage of fibers
expressing MHC-2b) in MDX mice. It is well established that
slow/oxidative fiber are more fatigue resistant than fast/glycolytic
fibers [20]. Since the calcineurin, PGC-1a, and PPAR signaling
pathways promote the formation of slow/oxidative/fatigue
resistant fiber [3], these pathways could be less activated in
response to ML in MDX mice. The data concerning the
expression of NFATc, PGC-1a and PPAR-ß mRNAs in response
to ML in both strains did not support this hypothesis. However,
activation of these signaling pathways, in addition to modulation
of gene transcripts as analyzed in the present study, involves also
post-transcriptional modifications.
Interestingly, dystrophin rescue restored these aspects of the
adaptive response to ML, substantiating the idea that the absence
of dystrophin is responsible of the defect. It should be noted that
partial dystrophin replacement appears to be enough, confirming
previous studies [58]. Apparently, the dystrophic state does not
play a role in the reduced adaptive response since dystrophin
rescue restores it, whithout affecting the level of fibrosis.
Therefore, a key finding of the present study is that dystrophin
is very likely a new player in the adaptive response to ML.
Potential mechanisms of the fiber atrophy
In the present study, the reduced muscle hypertrophy (increase
in muscle weight) in response to 2 month-ML in MDX mice is not
caused by a smaller increase in fiber number per muscle cross-
sectional area (similar increase). Fiber number increase following
ML have been previously reported [7,19,24,40], and most
probably results from both de novo fiber formation from satellite
cells and fiber splitting/branching since the increased fiber
number is only partially attenuated with satellite cell ablation
[19]. This is the atrophy of the fibers expressing MHC-2b and
MHC-2a that is responsible for the reduced muscle hypertrophy in
MDX+ML mice. This may result from the lower reduction in
catabolic processes (ubiquitin-proteasomal pathway and autopha-
gy) in MDX+ML, in agreement with the lower increase in Akt
phosphorylation. It is also likely that split/branched and newly
formed fibers did not grow enough in the MDX+ML mice. A
possible lower contribution of satellite cells to muscle hypertrophy
resulting from dystrophic environment is not supported by our
results concerning the increase in fiber number (similar between
the 2 strains) and the effect of dystrophin rescue (restoration of the
adaptive response without notable change in the dystrophic
environment), and the recent finding that satellite cells are not
necessary for robust ML-induced hypertrophy [19].
The increase in fiber number following ML is independent of
mTOR signaling whereas fiber growth is not [6]. Therefore, we
propose that the splitted/branched and newly formed fibers did
not grow enough in the MDX+ML mice due to reduced mTOR
signaling in response to ML. In support of this hypothesis, we
found a lower increase in phosphorylation of rS6 in MDX+ML
mice. Moreover, phosphorylation of Akt is also increased to a
lesser extent; activation of Akt also promoting muscle hypertrophy
[8,9]. The reduced augmentation of follistatin and the reduced
attenuation of myostatin and REDD1 in response to ML in MDX
mice were consistent with the inhibition of mTOR activation
[12,13,15,16]. We have recently reported that AMPKa1 plays a
key role in suppressing mTOR activation and limits hypertrophy
in response to ML [10]. In the present study, we found that
AMPKa1 activity increased to a similar extent in response to ML
in MDX mice as compared to C57+ML; however AMPKa1
actvity was higher in MDX+ML mice.
Together with an inhibition of the mTOR pathway, it is also
possible that reduced mTOR signaling in MDX+ML mice
resulted from a lower input from mTOR activation during ML.
Recent studies have ruled out the theory that local production of
insulin-like growth factor (IGF-1) and IGF-1 signaling is
responsible for mTOR activation in response to ML [17,43,59].
This is consistent with the fact that IGF-1 does not either cause
hypertrophy nor activate Akt/mTOR signaling in (adult) muscle
[60]. How mTOR signaling is activated by mechanical signals is
not well understood [2,61]. However, mTOR activation in
response to ML is reduced by inhibition of mechanoreceptors
such as stretch-activated channels [62]. Therefore, the lower
activation of mTOR in MDX+ML mice may result from a
dysfunction in the mechanoreceptors due to colocalization of
dystrophin and mechanoreceptors [30,31].
Since dystrophin rescue increased the fiber diameter in
MDX+ML+DYS mice, this result substantiates the idea that
dystrophin plays an important role both in anabolic and catabolic
pathways, possibly due to the fact that dystrophin contributes to
force transmission [26] and serves as a scaffold for signaling
complexes [29,30,31]. Consistent with our results, it was reported
that dystrophin may be critical for muscle growth/maintenance
[63,64].
Conclusion
The extent of the improvement in muscle performance (gains in
absolute maximal force and fatigue resistance) in response to ML
was lower in dystrophic MDX mice. Decreased cellular and
molecularadaptations(hypertrophy,promotionofslower/oxidative
fibers) in response to ML and altered intracellular signaling
pathways involved in muscle growth and maintenance were also
found in MDX mice. The fact that dystrophin rescue restored the
muscleresponsetoMLfurthersubstantiatestheideathatdystrophin
plays an important role. Future studies are required to dissect the
detailed link between dystrophin and muscle growth and mainte-
nance. Additional studies are also needed to test the possibility that
long-term physical rehabilitation using high-force contractions
could be a safe therapeutic strategy to ameliorate dystrophic muscle
weakness.
Methods
Animals and mechanical overloading
All procedures were performed in accordance with national and
European legislations. Male MDX mice (MDX, C57BL/10ScSc-
DMD
mdx/J) and their control (C57, C57BL/10) were used at 4–6
months of age. The MDX mice were kindly provided by D.
Sassoon and A. Pannerec (INSERM U787 Paris). All animals were
housed in conventional conditions. The animals were anaesthe-
tized with pentobarbital (ip, 50 mg/kg body weight). The plantaris
muscles of both legs from each mouse were mechanically
overloaded (ML) by the surgical removal of soleus muscles and a
major portion of the gastrocnemius muscles as described [39].
Body weight was not changed by 2 month ML in both MDX and
C57 mice. The plantaris muscles were recovered 3 and 7 days,
and 1 and 2 months following ML. The animals were euthanized
with an overdose of pentobarbital.
Dystrophin rescue strategy
The restoration of a quasi-dystrophin was mediated by the
vectorized U7 exon-skipping technique (U7-DYS)[44]. Vectors
were prepared according to published protocols [45]. Adeno-
associated vectors (AAV2/1) carrying the U7-DYS construct were
injected in 6 MDX animals through intra-arterial perfusion of the
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12 vector genomes
(vg).ml
-1. Detailed procedure for intra-arterial injection was
previously described [46]. Briefly, anesthetized mice (2–4%
isoflurane) underwent femoral artery and vein isolation of the
right hindlimb. After clamping the femoral vein and two
collaterals, a catheter was introduced in the femoral artery and
we injected 1 ml per 20 g of body weight at a rate of 100 ml.s
-1.
Control muscle was obtained from left hind limb in which femoral
artery was injected with saline solution only. Muscles were
collected 1 month after ML.
Whole muscle force measurement
Skeletal muscle function was evaluated by measuring in situ
muscle contraction, as described previously [47,48]. At different
times after ML (1 and 2 months after ML), animals were
anesthetized (ip, pentobarbital sodium, 50 mg/kg). During physi-
ological experiments, supplemental doses were given as required to
maintaindeepanesthesia.Thekneeandfootwerefixedwithclamps
and stainless steel pins. The plantaris muscle was exposed and the
distal tendon of the gastronecmius and soleus muscle complex was
cut. The distal tendon of the plantaris muscle was attached to an
isometric transducer (Harvard Bioscience) using a silk ligature. The
sciatic nerves were proximally crushed and distally stimulated by a
bipolar silver electrode using supramaximal square wave pulses of
0.1 ms duration. Responses to tetanic stimulation (pulse frequency
50–143 Hz) were successively recorded. At least 1 min was allowed
between contractions. Absolute maximal forces were determined at
optimal length (length at which maximal tension was obtained
during the tetanus). Force was normalized to the muscle mass (m) as
an estimate of specific maximal force. Fatigue resistance was then
determined after a 5-min rest period. The muscle was continuously
stimulated at 50 Hz for 2 min (sub maximal continuous tetanus).
The duration corresponding to a 20% decrease in force was noted.
Body temperature was maintained at 37uC using radiant heat.
Single muscle fiber force measurement
Plantaris muscles were collected 2 months after ML and
immediately placed in an ice-cold relax solution (in mmol/l:
100 KCl, 20 Imidazole, 7 MgCl2, 2 EGTA, 4 ATP, pH 7.0; 4uC).
Small bundles of ,25–50 fibers were dissected free from the muscle
andtiedtoaglassmicrocapillarytubeat,110%restinglength.The
bundles were then placed in a skinning solution (relax solution
containing glycerol; 50:50 v/v) at 4uC for 24 h and subsequently
treatedwithacryoprotectant(sucrosesolution)forlong-termstorage
at 280uC as described earlier [49]. On the day of experiment, a
bundle was desucrosed and single fibers isolated. A fiber segment
length of 1 to 2 mm was then left exposed to the relax solution
between connectors leading to a force transducer (model 400A,
Aurora Scientific) and a lever arm system (model 308B, Aurora
Scientific). The apparatus was mounted on the stage of an inverted
microscope(modelIX70;Olympus).Whilethefibersegmentwasin
relax solution, sarcomere length was set to 2.5060.05 mmb y
adjusting the overall segment length. The sarcomere length was
controlled during the experiments using a high-speed video analysis
system (model 901A HVSL, Aurora Scientific). The fiber segment
width, depth and length between the connectors were measured.
Fiber cross-sectional area (CSA) was calculated from the diameter
and depth, assuming an elliptical circumference, and was corrected
for the 20% swelling that is known to occur during skinning. At
15uC,immediatelyprecedingeachactivation,thefibersegmentwas
immersed for 10–20 s in a solution with a reduced Ca
2+-EGTA
buffering capacity. This solution is identical to the relax solution
except that the EGTA concentration is reduced to 0.5 mM, which
results in more rapid attainment of steady force during subsequent
activation. Maximal isometric force was calculated as the difference
between the total force in activating solution (pCa 4.5) and the
resting force measured in the same segment while in the relax
solution. Maximal force was adjusted for fiber CSA (specific
maximal force). After mechanical measurements, each fiber was
placed in urea buffer in a plastic microcentrifuge tube and stored at
280uC until analyzed by gel electrophoresis. The myosin heavy
chain (MHC) isoform composition of fibers was determined by 6%
SDS-PAGE. The acrylamide concentration was 4% (wt/vol) in the
stacking gel and 6% in the running gel, and the gel matrix included
30% glycerol. Sample loads were kept small (equivalent to
,0.05 mm of fiber segment) to improve the resolution of the
MHC bands (slow and fast MyHC: type I, IIa, IIx and IIb).
Electrophoresis was performed at 120 V for 24 h with a Tris–
glycine electrode buffer (pH 8.3) at 15uC (SE 600 vertical slab gel
unit,HoeferScientificInstruments).Thegelsweresilver-stainedand
subsequently scanned in a soft laser densitometer (Molecular
Dynamics) with a high spatial resolution (50 mm pixel spacing) and
4096 optical density levels.
Histology
Transverse serial sections (8 mm) of muscles (collected 1 and 2
months after ML) were obtained using a cryostat, in the mid-belly
region. The muscles were sectioned at different intervals to
determinethemaximalmuscleCSAandthecorrespondingsections
were studied. Some of the sections were processed for histological
analysis according to standard protocols (stained for H&E, Sirius
red,dapi).Otherswereusedforimmunohistochemistryasdescribed
previously [50,51]. For determination of muscle fiber diameter and
myosin heavy chain (MHC) analysis, frozen unfixed sections were
blocked 1 h in PBS plus 2% BSA, 2% sheep serum and incubated
30 minwithmouseFab1/100inPBS.Sectionswerethenincubated
overnight with primary antibodies against laminin (Z0097, Dako),
dystrophin (anti-Dys1, Novocastra) and MHC isoforms (BAD5/
MHC-1, BF3/MHC-2b, SC71/MHC-2a,6H1/MHC-2x, F1652/
MHC-dev, Hybridoma bank). After washes in PBS, sections were
incubated 1 h with secondary antibodies (alexa fluor). After washes
in PBS, slides were finally mounted in Fluoromont (Southern
Biotech). Morphometric analyses were made on two serial sections
of muscles. Images were captured using a digital camera
(Hamamatsu ORCA-AG) attached to a motorized fluorescence
microscope (Zeiss AxioImager.Z1), and morphometric analyses
were made using the software MetaMorph 7.5 (Molecular Devices).
The smallest diameter of the fibers was measured. For muscle fiber
diameter and fiber typing analyses all of the muscle fibers of the
muscle section were measured. Unfortunately, it was not possible to
distinguish pure and hybrid fibers expressing MHC-2b and MHC-
2x since the isotype and species of the 2 primary antibodies were
similar. To evaluate the amount of fibrosis, we measured the cross-
sectional area occupied by Sirius red stained interstitial tissue.
AMPK activity assay
Muscles were recovered 7 days after ML (they were not
previously electrically stimulated) in order to assay AMK activity.
AMPK was immunoprecipitated from 30 mg lysate with antibodies
against the a1 catalytic subunit and assayed for phosphotransferase
activity towards AMARA peptide (AMARAASAAALARRR) using
[c-
32P]-ATPaspreviouslydescribed[52].AMPKa1antibodiesused
for immunoprecipitation was generated and donated by Professor
D. Grahame Hardie (University of Dundee)
Western blot analysis
Immunoblotting was carried out as described previously [47,53]
using muscles 7 days after ML (muscles were not previously
Mechanical Overloading and Absence of Dystrophin
PLoS ONE | www.plosone.org 9 April 2012 | Volume 7 | Issue 4 | e35346electrically stimulated) from overnight fasted mice. Muscle tissues
were snap frozen in liquid nitrogen immediately after dissection.
Frozen muscles were placed into an ice-cold homogenization buffer
containing: 50 mM Tris (pH 7.6), 250 mM NaCl, 3 mM EDTA,
3 mM EGTA, 0.5% NP40, 2 mM dithiothreitol, 10 mM sodium
orthovanadate, 10 mM NaF, 10 mM glycerophosphate and 2% of
protease inhibitor cocktail (Sigma, P8340). Samples were finely
minced with scissors and then homogenized using plastic pestles,
incubated 30 minutes on ice, sonicated 3 times for 5 s with 30 s
intervals on ice and then centrifuged at 12,000 g for 30 min at 4uC.
Protein concentration was measured using the Bradford method
withBSAasastandard.Equalamountsofproteinextracts,ie.10 mg
(phosphorylated-Ak,p-Akt),or20 mg(phosphorylated-ribosomalS6
protein, p-rS6) were separated by SDS-PAGE before electropho-
retic transfer onto a nitrocellulose membrane (Amersham Hybond-
ECL, GE Healthcare). Western-blot analysis was carried out using
p-rS6 (Ser240/244) antibody (1:2000, Cell Signaling #2215S); p-
Akt (Ser473) antibody (1:2000, Cell Signaling #9271S), and a pan-
actin Antibody (Clone C4, 1:20000, Millipore). Antibody reacting
bands were visualized with peroxidase-conjugated secondary
antibodies(PierceBiotechnology)andachemiluminescentdetection
system (ECL-Plus; GE Healthcare). Bands of actin were used to
check that the protein load was correct. Bands were quantified by
densitometric software (Multi Gauge, Fujifilm).
Relative quantification of gene expression by qPCR
Unstimulated muscles were collected 3 and 7 days after ML.
Total RNA was extracted from plantaris muscle using miRNeasy
Mini Kit (Qiagen SA) following the manufacturer’s instructions.
RNA quality for each sample was checked with Experion RNA
StdSens Analysis Kit and the Experion automated electrophoresis
station according to the manufacturer’s instructions. Only samples
with a RQI (RNA quality indicator) superior to 7 were used for
further studies. The first-strand cDNA was then synthesized using
Transcriptor First Strand cDNA Synthesis Kit (Roche Diagnostics)
with Anchored-oligo(dT)18 primer and according to the manufac-
turer’s instructions. PCR analysis was then carried out with SYBR
green PCR technology using Light Cycler 480 system (Roche
Diagnostics). The reaction was carried out in duplicate for each
sample in a 8 ml reaction volume containing 4 ml of SYBR Green
Master Mix and 500 nM each the forward and reverse primer, and
4 ml of diluted (1:25) cDNA. The thermal profile for SYBR Green
qPCR was 95uC for 8 min, followed by 40 cycles at 95uC for 15 s,
60uC for 15 s, 72uC 30 s. Primers sequences used in this study are
available on request. The gene expression stability of GAPDH,
HPRT and P0 were calculated using geNorm software and after
analysis only HPRT and P0 were used as the references transcripts.
Statistical analysis
Groups were statistically compared using analysis of variance. If
necessary, subsequent contrast analysis was also performed. For
groups that did not pass tests of normality and equal variance,
non-parametric tests were used (Kruskal Wallis and Wilcoxon).
Values are means 6 SEM.
Supporting Information
Figure S1 Factors promoting fast/glycolytic to slow/
oxidative fiber-type conversion after 7 days of ML.
PPARß (a), PGC1a (b) and NFATc1a (c) mRNA after 7 days of
ML. a: significantly different from unoverloaded muscle (p,0.05).
b: significantly different from corresponding C57 mice (p,0.05).
n=6/group.
(TIF)
Figure S2 Changes in catabolic processes following ML
in MDX mice after 3 and 7 days of ML. Atrogin-1
(ubiquitin-proteasomal pathway)(a), LC3 (b) and Bnip3 (autopha-
gy)(c) mRNA at 3 and 7 days. a: significantly different from
unoverloaded muscle (p,0.05). b: significantly different from
corresponding C57 mice (p,0.05). n=5–10/group.
(TIF)
Figure S3 Cellular effects of dystrophin rescue at 1
month following ML in MDX mice. (a) representative image
of fibers expressing dystrophin in MDX+ML+DYS mice, (b, c)
fibrosis using red Sirius staining and (d) diameter of fibers
expressing (DYS positive) or not dystrophin (DYS negative) in
MDX+ML mice. c: significantly different from fiber expressing not
dystrophin (p,0.05). n=4–6/group.
(TIF)
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